- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Kiniksa Pharmaceuticals (NASDAQ:KNSA), Quotes and News Summary
Kiniksa Pharmaceuticals (NASDAQ: KNSA)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Kiniksa Pharmaceuticals Questions & Answers
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ: KNSA) through any online brokerage.
Other companies in Kiniksa Pharmaceuticals’s space includes: Avidity Biosciences (NASDAQ:RNA), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL), Sangamo Therapeutics (NASDAQ:SGMO) and Agenus (NASDAQ:AGEN).
The latest price target for Kiniksa Pharmaceuticals (NASDAQ: KNSA) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting KNSA to fall to within 12 months (a possible -67.77% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $12.41 last updated August 12, 2022, 8:00 PM UTC.
The next Kiniksa Pharmaceuticals (KNSA) dividend date is projected to be Thursday, September 1, 2022.
Kiniksa Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.